Skip to main content

Month: February 2020

Risk Strategies Acquires UNIRISC, Inc.

BOSTON, Feb. 18, 2020 (GLOBE NEWSWIRE) — Risk Strategies, a privately held, rapidly growing national insurance brokerage and risk management firm, today announced that it has acquired UNIRISC, Inc., a leading specialist in the global relocation insurance and risk management needs of corporate personnel and private individuals moving domestically and overseas. Terms of the deal were not disclosed.Founded in 1972 and based in Arlington, Virginia, UNIRISC’s clients include a broad swath of leading Fortune 100 companies spanning the automotive, financial, pharmaceutical, insurance, service, manufacturing, communications, technology, and relocation industries. Employers, relocation management firms, movers, and forwarders, as well as successful families and private individuals, rely on UNIRISC’s services. These include claims services...

Continue reading

EastGate Biotech Pakistan Expands its Collaboration in Advancing the Development of a New Vaccine Against COVID-19

Joint Venture Collaboration to also pursue antibiotic products to create a pipeline to fight various new strains of flu illnessesWEST CALDWELL, NJ and TORONTO, ON, Feb. 18, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — /NEWMEDIAWIRE/ February 18, 2020/EastGate Biotech Corp. (OTC: PINK: ETBI), a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of Type 2 diabetes, announced today that the company along with its Joint Venture Partner EastGate Biotech Pakistan have agreed to move forward with the development of a new vaccine to combat Coronavirus COVID-19 in China and others affected around the globe.EastGate Biotech Pakistan has access to existing vaccine production companies; some of which already have experience with MERS coronavirus and who are...

Continue reading

PAVmed Adds EsoCure™ Esophageal Ablation Device with Patented Caldus™ Technology to Commercial Product Pipeline

Disposable single-use device designed to provide safer, more efficient and cost-effective ablation of dysplastic Barrett’s Esophagus, complementing Lucid Diagnostics’ EsoGuard™ and EsoCheck™ productsNEW YORK, Feb. 18, 2020 (GLOBE NEWSWIRE) — PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced it has added the EsoCure™ Esophageal Ablation Device with Caldus™ Technology to its commercial product pipeline.EsoCure’s disposable single-use thermal balloon ablation catheter is designed to advance through the working channel of a standard endoscope and allow the clinician to treat dysplastic Barrett’s Esophagus (BE) before it can progress to highly lethal esophageal cancer (EAC) and to do so without the need for complex and expensive capital equipment....

Continue reading

HC2 Holdings Issues Statement Regarding Percy Rockdale’s Nomination of Directors

NEW YORK, Feb. 18, 2020 (GLOBE NEWSWIRE) — HC2 Holdings, Inc. (“HC2” or the “Company”) (NYSE: HCHC), a diversified holding company, issued the following statement regarding Percy Rockdale LLC’s (“Percy Rockdale”) nomination of six candidates for election to HC2’s Board of Directors at the Company’s 2020 Annual Meeting of Stockholders. “HC2 respects and values input from all of its stockholders. To that end, the Nominating and Governance Committee of HC2’s Board of Directors will carefully review Percy Rockdale’s proposed candidates in due course, and make a recommendation it believes is in the best interests of all stockholders.“HC2 has offered to speak on multiple occasions with Percy Rockdale in an attempt to satisfy their concerns in a cooperative manner that benefits all stockholders. To the Company’s surprise and disappointment,...

Continue reading

Exactus Inc. appoints Derek Du Chesne as Chief Growth Officer and announces Company to present at NobleCon16

DELRAY BEACH, Fla., Feb. 18, 2020 (GLOBE NEWSWIRE) — Exactus, Inc. (OTCQB:EXDI) (the “Company”), a hemp farmer and manufacturer of hemp-derived phytocannabinoid products, today announced that it has appointed Derek Du Chesne as Chief Growth Officer and the company will be presenting at the NobleCon16 Investor Conference.Exactus welcomes Derek Du Chesne who joins the company as Chief Growth Officer. Prior to joining Exactus, Derek was responsible for securing over $40 million in funding for his previous company, he is an expert in the hemp industry with a large network of connections.  Mr. Du Chesne is a brand management professional who has a proven track record of integrated marketing strategy, through concept, development, and launch, building iconic brands by orchestrating successful campaign deployment on both a global and regional...

Continue reading

Lerøy Seafood Group ASA: Invitation to presentation of results for Q4 2019

Lerøy Seafood Group ASA will announce the financial results for the 4th quarter 2019 on Tuesday 25 February 2020 at 08:00 at Hotel Continental, Teatersalen 1, Stortingsgaten 24/26, Oslo. The presentation will start with a delicious seafood buffet served at 07:45.Please note that the quarterly report and presentation will be published at 06:30 CET. The presentation will also be available on Norwegian web cast at 08:00 am and English web cast from 01:00 pm on www.leroyseafood.comWelcome!This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Continue reading

Lerøy Seafood Group ASA: Invitasjon til presentasjon av resultater for 4. kvartal 2019

Lerøy Seafood Group ASA presenterer resultater for 4. kvartal 2019 tirsdag den 25. februar 2020 klokken 08.00 på Hotel Continental, Teatersalen 1, Stortingsgaten 24/26, Oslo. Det blir servering av smakfull sjømatbuffet fra klokken 07.45.Kvartalsrapporten og presentasjonen vil bli offentliggjort kl. 06.30. Presentasjonen vil også kunne følges på norsk web cast på www.leroyseafood.com klokken 08.00 og engelsk web cast fra klokken 13.00.Velkommen!Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12

Continue reading

BROOGE HOLDINGS ANNOUNCES NOTIFICATION OF ADDITIONAL END USERS AND INTEREST OF CURRENT CUSTOMER IN PHASE III OFFTAKE

NEW YORK, Feb. 18, 2020 (GLOBE NEWSWIRE) — Brooge Holdings Limited (“Brooge Holdings”) (NASDAQ: BROG) and its wholly-owned subsidiary Brooge Petroleum and Gas Investment Company FZE (“BPGIC”), a Fujairah Free Zone Entity in the oil storage and services business announced today that BPGIC received notification from its Phase I offtake customer, Al Brooge International Advisory LLC (“BIA”), that strong demand for oil storage and product handling in the port of Fujairah resulted in a number of attractive oil storage and product handling requests from new international end users that, after completing proper due diligence, BIA accepted. As a result, BIA began providing oil storage and handling services in prior periods to a broader base of end users and established a successful track record with the same. BIA informed BPGIC that it expects...

Continue reading

Agritek Holdings, Inc. Named Number One Short Term Cannabis Stock on Top 25 List by CANNAINVESTOR Magazine for Week of February 17th 2020

LOS ANGELES, CA, Feb. 18, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Agritek Holdings, Inc. (AGTK) www.AgritekHoldings.com, a fully integrated, active real estate investor and white label provide for popular hemp brands, today announced that the Company was named the number one from a list of 25 undervalued cannabis companies as the top short term investment by CANNAINVESTOR Magazine this week.

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.